AKT1 and Cognitive impairment: Therefore, inhibiting the expression or promoting the degradation of miR-204-5p and miR-1297 may be a potential therapeutic method for treating general anesthetic-induced neurotoxicity and cognitive impairment in the developing brain by indirectly upregulating the Akt signaling pathway, which can inhibit neuronal apoptosis.